Baxter International (BAX) Q2 2012 Earnings Call July 19, 2012 8:30 am ET Executives Mary Kay Ladone - Vice President of Investor Relations Robert L. Parkinson - Chairman, Chief Executive Officer and President Robert J. Hombach - Chief Financial Officer and Corporate Vice President Norbert G. Riedel - Chief Scientific Officer and Corporate Vice President Analysts David H. Roman - Goldman Sachs Group Inc., Research Division Michael N. Weinstein - JP Morgan Chase & Co, Research Division David R. Lewis - Morgan Stanley, Research Division Rajeev Jashnani - UBS Investment Bank, Research Division Robert A. Hopkins - BofA Merrill Lynch, Research Division Lawrence S. Keusch - Raymond James & Associates, Inc., Research Division Matthew S. Miksic - Piper Jaffray Companies, Research Division Kristen M. Stewart - Deutsche Bank AG, Research Division PresentationOperator
Good morning, ladies and gentlemen, and welcome to Baxter International's Second Quarter Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission. If you have any objections, please disconnect at this time. I would now like to turn the call over to Ms. Mary Kay Ladone, Corporate Vice President, Investor Relations, at Baxter International. Ms. Ladone, you may begin. Mary Kay Ladone Thanks, Kevin, and good morning, everyone, and welcome to our Q2 2012 earnings conference call. Joining me today are Bob Parkinson, CEO and Chairman of Baxter International; Bob Hombach, Chief Financial Officer; and Dr. Norbert Riedel, Chief Science and Innovation Officer.